1
van der Putten, Ingeborg M., Paulus, Aggie T. G., Hiligsmann, Mickael, Hutubessy, Raymond C. W., Evers, Silvia M. A. A.
Veröffentlicht in: van der Putten , I M , Paulus , A T G , Hiligsmann , M , Hutubessy , R C W & Evers , S M A A 2019 , ' Evidence-informed vaccine decision making : The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands ' , Health Policy , vol. 123 , no. 3 , pp. 260-266 . https://doi.org/10.1016/j.healthpol.2018.09.001;
2019
Veröffentlicht in: van der Putten , I M , Paulus , A T G , Hiligsmann , M , Hutubessy , R C W & Evers , S M A A 2019 , ' Evidence-informed vaccine decision making : The introduction of Human Papilloma Virus (HPV) vaccination in the Netherlands ' , Health Policy , vol. 123 , no. 3 , pp. 260-266 . https://doi.org/10.1016/j.healthpol.2018.09.001;
2019
2
3
4
5
6
7
Gefenaite, Giedre, Smit, Marieke, Nijman, Hans W, Tami, Adriana, Drijfhout, Ingrid H, Pascal, Astrid, Postma, Maarten J, Wolters, Bert A, van Delden, Johannes J M, Wilschut, Jan C, Hak, Eelko
Veröffentlicht in: Gefenaite , G , Smit , M , Nijman , H W , Tami , A , Drijfhout , I H , Pascal , A , Postma , M J , Wolters , B A , van Delden , J J M , Wilschut , J C & Hak , E 2012 , ' Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands : Insights from a behavioral survey among parents ' , BMC Public Health , vol. 12 , 498 . https://doi.org/10.1186/1471-2458-12-498;
2012
Veröffentlicht in: Gefenaite , G , Smit , M , Nijman , H W , Tami , A , Drijfhout , I H , Pascal , A , Postma , M J , Wolters , B A , van Delden , J J M , Wilschut , J C & Hak , E 2012 , ' Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands : Insights from a behavioral survey among parents ' , BMC Public Health , vol. 12 , 498 . https://doi.org/10.1186/1471-2458-12-498;
2012
8
Simons, Joost J. M., Vida, Nora, Westra, Tjalke A., Postma, Maarten J.
Veröffentlicht in: Simons , J J M , Vida , N , Westra , T A & Postma , M J 2020 , ' Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands ' , Vaccine , vol. 38 , no. 30 , pp. 4687-4694 . https://doi.org/10.1016/j.vaccine.2020.05.031;
2020
Veröffentlicht in: Simons , J J M , Vida , N , Westra , T A & Postma , M J 2020 , ' Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands ' , Vaccine , vol. 38 , no. 30 , pp. 4687-4694 . https://doi.org/10.1016/j.vaccine.2020.05.031;
2020
9
Swart, Esther M., Noordhof, Anneloes L., Damhuis, Ronald A. M., Kunst, Peter W. A., De Ruysscher, Dirk K. M., Hendriks, Lizza E. L., van Geffen, Wouter H., Aarts, Mieke J.
Veröffentlicht in: Swart , E M , Noordhof , A L , Damhuis , R A M , Kunst , P W A , De Ruysscher , D K M , Hendriks , L E L , van Geffen , W H & Aarts , M J 2023 , ' Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors ' , Lung Cancer , vol. 182 , no. 1 , 107290 . https://doi.org/10.1016/j.lungcan.2023.107290;
2023
Veröffentlicht in: Swart , E M , Noordhof , A L , Damhuis , R A M , Kunst , P W A , De Ruysscher , D K M , Hendriks , L E L , van Geffen , W H & Aarts , M J 2023 , ' Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors ' , Lung Cancer , vol. 182 , no. 1 , 107290 . https://doi.org/10.1016/j.lungcan.2023.107290;
2023
10